Quick Answer
Kraig Biocraft Laboratories, Inc. reported Stockholders Equity of -$8.00 million for the year ending 2025.
- Kraig Biocraft Laboratories, Inc. showed an increase of +1.8% in Stockholders Equity from 2024 to 2025.
- This data is from Kraig Biocraft Laboratories, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: -$5.39 million | Q1 2020: -$5.89 million | Q2 2020: -$6.31 million | Q3 2020: -$6.84 million | Q1 2021: -$6.88 million | Q2 2021: -$5.02 million | Q3 2021: -$5.90 million | Q1 2022: -$4.10 million | Q2 2022: -$3.77 million | Q3 2022: -$3.79 million | Q1 2023: -$4.04 million | Q2 2023: -$4.51 million | Q3 2023: -$5.00 million | Q1 2024: -$6.24 million | Q2 2024: -$6.97 million | Q3 2024: -$7.36 million | Q1 2025: -$8.47 million | Q2 2025: -$8.47 million | Q3 2025: -$7.96 million.
- Over the full 18 years of available data (2008 to 2025), Kraig Biocraft Laboratories, Inc.'s Stockholders Equity has declined by 321.1%.
- Historical annual values: Fiscal year 2025: -$8.00 million | Fiscal year 2024: -$8.15 million | Fiscal year 2023: -$5.71 million | Fiscal year 2022: -$3.52 million | Fiscal year 2021: -$5.30 million | Fiscal year 2020: -$6.57 million | Fiscal year 2019: -$5.39 million | Fiscal year 2018: -$4.46 million | Fiscal year 2017: -$3.38 million | Fiscal year 2016: -$2.36 million | Fiscal year 2015: -$1.90 million | Fiscal year 2014: -$1.23 million | Fiscal year 2013: -$1.20 million | Fiscal year 2012: -$1.13 million | Fiscal year 2011: -$906.5 thousand | Fiscal year 2010: -$619.2 thousand | Fiscal year 2009: -$3.17 million | Fiscal year 2008: -$1.90 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: